The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
ADVERUM BIOTECHNOLOGIES INC | COM | 00773U108 | 2,609 | 828,262 | SH | SOLE | 828,262 | 0 | 0 | ||
CONSTELLIUM NV | CL A | N22035104 | 114,593 | 16,393,903 | SH | DFND | 1 | 0 | 16,393,903 | 0 | |
CRITEO S A | SPONS ADS | 226718104 | 61,770 | 2,718,752 | SH | DFND | 1 | 0 | 2,718,752 | 0 | |
DBV TECHNOLOGIES S A | SPONSORED ADR | 23306J101 | 5,348 | 833,042 | SH | DFND | 1 | 0 | 833,042 | 0 | |
MILLENDO THERAPEUTICS INC | COM | 60040X103 | 8,575 | 1,078,670 | SH | DFND | 2 | 0 | 1,078,670 | 0 | |
MITEK SKS INC | COM NEW | 606710200 | 2,756 | 254,941 | SH | DFND | 2 | 0 | 254,941 | 0 | |
SEQUANS COMMUNICATIONS S A | SPONS ADS | 817323108 | 9,427 | 12,085,561 | SH | DFND | 1 | 0 | 12,085,561 | 0 | |
TALEND S A | ADS | 874224207 | 78,346 | 2,112,895 | SH | DFND | 2 | 0 | 2,112,895 | 0 | |
TECHNIPFMC PLC | COM | G87110105 | 498,940 | 24,688,691 | SH | DFND | 1 | 0 | 24,688,691 | 0 |